Such combinatorial nanoplatforms integrating photodynamic therapy and TRAIL potentiation exemplify a precision strategy to induce immunogenic apoptosis and sensitize resistant BC cells, particularly in triple-negative subtypes, where therapeutic options are limited. The gene discussed is TNFSF10; the disease is breast cancer.